ALBA Synchrotron’s Post

Pushing the boundaries in brain cancer therapy: Unveiling Tyrosine Kinase Inhibitors for glioblastoma. Targeting the enzymes that signal cancer growth, TKIs offer a sharp attack on malignant cells, sparing the healthy ones. Marking progress with potential to enhance with chemo or radiation, this strategy is rewriting the glioblastoma battle plan. Discover this clinical trial's journey at medohhealth.com #BrainCancerInnovation #GlioblastomaTreatment #TKITherapy #CancerResearchAdvances #HealthcareBreakthrough #MedohHealth #ClinicalTrialsJourney #OncologyProgress #CancerCareFuture #MedicalScienceUpdates

Updates From the #FDA: The PD-L1 IHC 22C3 pharmDx companion diagnostic tool is now FDA-approved in gastric or GEJ adenocarcinoma, FTD granted to SONALA-001 INSIGHTEC Exablate 4000 Type-2 Device for the treatment of patients with rare brain cancer. #gicsm 1. https://lnkd.in/gAvJVMpN 2. https://lnkd.in/gshAPMs2

For patients who present with advanced stage cervical cancer, targeted therapies can improve outcomes. Join us for a molecular tumor board as we discuss treatment options for patients with recurrent cervical cancer and how biomarker-directed therapies are transforming the standard of care. #MolecularTumorBoard #PrecisionOncology #CervicalCancer

For patients who present with advanced stage cervical cancer, targeted therapies can improve outcomes. Join us for a molecular tumor board as we discuss treatment options for patients with recurrent cervical cancer and how biomarker-directed therapies are transforming the standard of care. #MolecularTumorBoard #PrecisionOncology #CervicalCancer

For patients who present with advanced stage cervical cancer, targeted therapies can improve outcomes. Join us for a molecular tumor board as we discuss treatment options for patients with recurrent cervical cancer and how biomarker-directed therapies are transforming the standard of care. #MolecularTumorBoard #PrecisionOncology #CervicalCancer

For patients who present with advanced stage cervical cancer, targeted therapies can improve outcomes. Join us for a molecular tumor board as we discuss treatment options for patients with recurrent cervical cancer and how biomarker-directed therapies are transforming the standard of care. #MolecularTumorBoard #PrecisionOncology #CervicalCancer

A new study offers hope for thousands impacted each year by aggressive brain cancer, glioblastoma. Scientists at the University of Sussex led an international research team to understand the possible reasons for resistance to treatment drugs, helping to guide future therapies to improve quality of life and increase life expectancy for those with glioblastoma. In the study, published in the journal of Advanced Science, researchers have discovered that an understudied protein, called PANK4, is able to block cancer cells from responding to chemotherapeutic treatment for the highly intrusive brain cancer. #ResearchWithImpact https://ow.ly/f4PY50QF4as

#bladdercancer 🔬 💉 Circulating tumor DNA (ctDNA) tumor fraction can predict survival in advanced bladder cancer patients! Higher ctDNA = worse outcome. Early detection & targeted treatment crucial link in the comment 🔻 🔻🔻

For patients who present with advanced stage cervical cancer, targeted therapies can improve outcomes. Join us for a molecular tumor board as we discuss treatment options for patients with recurrent cervical cancer and how biomarker-directed therapies are transforming the standard of care. #MolecularTumorBoard #PrecisionOncology #CervicalCancer

For patients who present with advanced stage cervical cancer, targeted therapies can improve outcomes. Join us for a molecular tumor board as we discuss treatment options for patients with recurrent cervical cancer and how biomarker-directed therapies are transforming the standard of care. #MolecularTumorBoard #PrecisionOncology #CervicalCancer